Fresenius Medical Care AG (FMCQF) Gains from Sales and Divestitures (2016 - 2017)

Fresenius Medical Care AG (FMCQF) recorded quarterly Gains from Sales and Divestitures of $32.2 million in Q4 2017, up 510.23% quarter-over-quarter from $5.3 million in Q4 2016, and up 510.23% on a YoY basis from $5.3 million in Q4 2016.

Fresenius Medical Care AG (FMCQF) Gains from Sales and Divestitures (2016 - 2017) Analysis & Trends

Fresenius Medical Care AG's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $32.2 million for Q4 2017.

  • In Q4 2017, Gains from Sales and Divestitures rose 510.23% year-over-year to $32.2 million; the TTM figure through Dec 2017 stood at $32.2 million (up 510.23% YoY), while the FY2017 annual figure was $32.2 million, up 510.23% from the prior year.
  • Gains from Sales and Divestitures was $32.2 million for Q4 2017 at Fresenius Medical Care AG, up from $5.3 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $32.2 million in Q4 2017 to a low of $5.3 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 Fresenius Medical Care AG - - -4.26 Bn

Historic Data

Download Data
DateValue
Dec 31, 2017 32.17 Mn
Dec 31, 2017 32.17 Mn
Dec 31, 2016 5.27 Mn
Dec 31, 2016 5.27 Mn